Cella Medical Solutions

Executive Summary

Cella Medical Solutions is a Spanish medtech company specializing in patient-specific 3D anatomical models for surgical planning, focusing on soft tissue surgeries. Founded in 2014, the company's web-based platform transforms medical images into validated reconstructions, enabling surgeons to anticipate risks, optimize clinical decisions, and improve surgical precision. With a growing emphasis on personalized medicine and minimally invasive procedures, Cella addresses a critical need in complex surgeries such as oncology and transplant. The company is privately held and has not disclosed funding or valuation, but its innovative approach positions it in a niche but expanding market. While competition exists from in-house hospital solutions and other 3D modeling firms, Cella's validated reconstructions and cloud-based delivery offer scalability and ease of adoption. The outlook is promising as healthcare providers increasingly adopt digital surgery tools.

Upcoming Catalysts (preview)

• Q2 2026Commercial partnerships with major hospital networks in Europe60% success
• Q4 2026Launch of AI-enhanced segmentation platform50% success
• Q3 2026Publication of clinical outcomes study in peer-reviewed journal70% success